Navigation Links
Researchers use 3-D imaging system to unveil swimming behavior of microscopic plankton

ratory at Scripps. "I find it fascinating and remarkable that we can capture the reflection of such tiny creatures in three dimensions from two meters away."

The divers frequented the underwater setup to sample the animals, reorient the transducer and measure the vertical currents using various methods, including releasing and tracking fluorescent dye and with state-of-the-art acoustic current meters.

Downward-flowing water in the ocean is always accompanied by horizontal flows, forming a convergence, or "downwelling" zone. When zooplankton swim upward against such a downward current, they form patches as more and more individuals are brought in with the horizontal currents and concentrated in the downwelling zone.

The scientists say the ecological implications of the zooplankton's depth-keeping behavior carry far-reaching consequences for predatory fishes, whales and humans.

Predators can dependably locate zooplankton aggregations by tracking well-defined cues, for example, sharp temperature gradients that occur across downwelling fronts where cold and warm waters meet. Vertical currents are common in many oceanic regions, including mid-ocean fronts, shelf breaks, submarine canyons and submerged banks.

"That small zooplankton are capable of remaining at a constant depth with a precision of centimeters, sometimes in the face of strong vertical currents, is incredible," said Genin. "It implies that these organisms have extremely sensitive depth sensors, the nature of which is yet unknown. That depth-keeping behavior has evolved in so many different species implies that this energetically demanding behavior provides significant, yet poorly understood benefits. Revealing those benefits and the nature of depth sensing will be a major and exciting challenge for future research in zooplankton ecology and evolution."


'"/>

Source:University of California - San Diego


Page: 1 2 3

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain

Post Your Comments:
(Date:11/4/2009)...TY, Calif., Oct. 20 DigitalPersona...ntication solutions, today announced that WAND Cor...) software for quick-service restaurants, has inte...n POS and Classic POS solutions. WAND,s quick-serv...o boost cashier accountability and deter unauthori...
(Date:11/4/2009)...Calif., Oct. 23 GenVault Corporati...nagement for genomic discovery, medicine and ident...., GenVault,s President and CEO, will be presentin...n October 26th and 27th in La Jolla, CA. ,, Dur...verview of the company together with recent custom...
(Date:11/4/2009)...HILL Scientists at the University of North Caroli...rsity of California, San Francisco have developed ...ew target diseases for existing drugs. , The res...pares how similar the structures of all known drug...-- known as ligands -- of disease targets within t...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Study points to new uses, unexpected side effects of already existing drugs 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 5330 1LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 5330 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 5330 3Chris Jensen Medical Center Saves Estimated 24600 000 in First Year of Safe Patient Handling 5328 1Chris Jensen Medical Center Saves Estimated 24600 000 in First Year of Safe Patient Handling 5328 2Chris Jensen Medical Center Saves Estimated 24600 000 in First Year of Safe Patient Handling 5328 3CVS pharmacys Transportation Operations Receives Two National Safety Awards 5326 1CVS pharmacys Transportation Operations Receives Two National Safety Awards 5326 2
... National Academy of Sciences , Yale researchers u... huge amounts of data on physical characteristics ...n habitats and metabolic activity in marine micro-...ed detail how environment influences molecular cha...bbed "metagenomics" progresses, scientists might b...
...threats to biodiversity and in many cases they hav... For their effective management it is important to...highest risk of being invaded. , The first map of...ion was published in the Wiley-Blackwell journal ...team of Czech, Spanish and British plant ecologist...
...your response to a radiological incident? How will... take care of us? How do we even know if we are ex...ll be addressed at the 42nd Midyear Topical Meetin...take place January 31-Feb 3, 2009 in San Antonio, ...The topic is "Recent Advances in Planning and Resp...
Other Biology News:Mixing genomics and geography yields insights into life and environment 242nd Mid-year Topical Meeting of the Health Physics Society 2
(Date:11/6/2009)..., Mass., Nov. 6 Myriant Technologi...loper and manufacturer of renewable bio-chemicals...chnology provider Uhde GmbH, one of the world,s le...nounced an alliance for the engineering, procureme...Succinic Acid plants based on renewable feedstocks...
(Date:11/6/2009)...D, Calif., Nov. 6 Intarcia Therape...ts ITCA 650 (DUROS® continuous delivery of ex...tes at the Ninth Annual Diabetes Technology Meetin...ewscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,... Via ITCA 650 Lowers Plasma Glucose, HbA1c and Red...
(Date:11/5/2009)...PANY, N.J., Nov. 5 DSM Pharmaceuti...nufacturing alliance with Galenix, Saint Jean D,Il...rcial scale manufacturing partner for Galenix comm...alenix will collaborate on business development op...hnologies, based on the strength of Galenix in dru...
(Date:11/5/2009)...OK, N.Y., Nov. 5 BioSpec...armaceutical company developing first-in-class col...cial results for the third quarter ended September...n September of this year, the FDA,s Arthritis Advi...of 12-0, the approval of XIAFLEX(TM) for the treat...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...ELPHIA, July 31 /PRNewswire-FirstCall/,-- Shire Li...ty,biopharmaceutical company announces results for...inancial Highlights, - Product sales up 40% to $7...4% to $409m - New product sales(1) $243m, 34% of ... to $776m - US GAAP earnings per ADS: loss $0.44 ...
... Health, a,global provider of products and service...th care, today announced a three-year agreement wi... pharmacy benefit managers,to serve as its primary...maceuticals, effective August 1., Prime Therapeut... drug,spend in 2007, and currently serves approxim...
...ook, MELVILLE, N.Y., July 31 Gentiva Health,Serv...provider of,comprehensive home health services, to... double-digit increases in Medicare revenues and a...(Logo: http://www.newscom.com/cgi-bin/prnh/200603...quarter ended June 29, 2008 included:, -- A 13% i...
Other Biology Technology:Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 2Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 3Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 4Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 5Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 6Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 7Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 8Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 9Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 10Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 11Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 12Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 13Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 14Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 15Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 16Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 17Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 18Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 19Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 20Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 21Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 22Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 23Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 24Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 25Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 26Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 27Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 28Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 29Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 30Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 31Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 32Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 33Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement 2Gentiva Reports Strong Second Quarter led by Home Health Segment 2Gentiva Reports Strong Second Quarter led by Home Health Segment 3
Mouse Anti-Mouse Qa.m8 Monoclonal Antibody, Unconjugated, Clone 5035-24.1 from CEDARLANE Laboratories Limited
...s at the 9, 10, 12, and 13 positions. It is intend...ication of 13(S)-HODE by GC- or LC-mass spectromet...ic acid with plant and mammalian lipoxygenases. It...ells to the endothelium at concentrations around 1...
pcDNA4/His A B & C from Invitrogen
Adaptor Hind III - Sma I from Takara Mirus Bio
Biology Products: